Eosdx Uk
Organization
Grants and prizes
Collaborative R&D, Game-changing breast cancer diagnosis: AI-driven, low-cost, non-invasive structural biomarker test for faster, accurate results and better treatments access, 10149297, £507K, 2025–2026, May 1, 2025
Collaborative R&D, NISTA: a novel non-invasive, data-enabled ML tool enabling earlier and more accurate diagnosis of pancreatic cancer, stratifying patients into more personalised treatment pathways to improve outcomes., 10085226, £695K, 2023–2025, Dec 1, 2023
Collaborative R&D, Non-invasive structural tissue analysis for low-cost, highly accurate, safe and rapid cancer diagnosis., 10063925, £385K, 2023–2024, Jul 1, 2023
Sources: gtr.ukri.org